Basic Research on Hormonal Treatment of Pancreatic Cancer
Basic Research on Hormonal Treatment of Pancreatic Cancer
批准号:
02670595
负责人:
UCHIDA Eiji
金额:
$1.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
1.人胰腺组织雌二醇(E_2)和雌激素受体(ER)的研究免疫组织化学检测22例中有17例出现E2阳性细胞。急诊室几乎是阴性的。结论:1.冰冻组织中ER生化检测为阴性。胰腺癌组织中表皮生长因子、表皮生长因子受体和c-erbB-2蛋白的免疫组织化学表达胰腺癌组织中EGF、EGFR和c-erbB-2蛋白阳性率分别为72%、36%和28%。这三种蛋白检测呈阳性的患者的生存期在统计学上比检测为阴性的患者要短。用核仁组成区(NORs)银染法研究人胰腺癌细胞的增殖能力。胰腺良性(正常:1.86;+-gt;0.38,胰腺炎:2.14;+-gt;0.53)和恶性(4.02;+-gt;1.19)胰腺组织(p<;0.01)之间的Ag-NORs指数有显著差异。胰腺癌的AG-NORs指数明显低于胃癌组(6.35;+-1.32)和结肠癌(7.66;+-MI4)。以Wistar-Bonn/Kobori大鼠(WBN/KOB)为模型,研究了WBN/KOB自发性胰腺炎和糖尿病的致癌作用。氮杂丝氨酸(50 mg/只,ip)不能诱发大鼠胰腺癌。接种7,12-二甲基苯并(A)菲诱发大鼠胰腺导管细胞样癌。
英文摘要
1. Studies on estradiol (E2) and estrogen receptor (ER) in human pancreatic tissues. E2-positive cells were immunohistochemically found in 17 of 22 cases. ER was almost negative. Biochemical assay of ER in frozen tissue was negative.2. Immunohistochemical expressions of epidermal growth factor (EGF), epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer. The positive rates of EGF, EGFR and the c-erbB-2 oncoprotein in pancreatic cncer tissues were 72%, 36% and 28%, respectively. The survival period for patients who tested positive for these three proteins was statisticaly shorter than for those who tested negative.3. The proliferating potential of human pancreatic cancer cells were studied by Ag-Nucleolar Organizer Regions (NORS) staining. A significant difference in Ag-NORs index was found between benign (normal : 1.86<plus-minus>0.38, pancreatitis : 2.14<plus-minus>0.53) and malignant (4.02<plus-minus>1.19) tissues of pancreas(p<0.01). Ag-NORs index in pancreatic carcinoma showed significantly lower value than that in cancer of stomach (6.35<plus-minus>1.32) and colon (7.66<plus-mi4. The Wistar Bonn/ Kobori rat (WBN/Kob) that is induced pancreatitis and diabetes mellitus spontaneously was studied for the carcinogenesis. Azaserine (50 mg/body, ip) did not induce pancreatic cancer in this rat. Inoculation of 7, 12-dimethylbenz(a)anthracene induced the duct cell-like carcinoma in pancreas of this rat as well as conventional Wistar rat.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
山中 洋一郎他: "ヒト膵臓癌におけるEpidermal Growth FactorおよびEpidermal Growth Factor Receptorに関する免疫組織化学的検討" 日本消化器病学会雑誌. 87. 1544-1550 (1990)
Yoichiro Yamanaka 等人:“人类胰腺癌中表皮生长因子和表皮生长因子受体的免疫组织化学研究”日本胃肠病学会杂志 87. 1544-1550 (1990)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y. Yamanaka, E. Uchida et al.: "Immunohistochemical study on epidermal growth factor and epidermal growth factor receptor in human pancreatic cancer" Jpn J Gastroenterol. 87. 1544-1550 (1990)
Y. Yamanaka、E. Uchida 等:“人胰腺癌中表皮生长因子和表皮生长因子受体的免疫组织化学研究”Jpn J Gastroenterol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T. Aimoto, E. Uchida et al.: "Study on proliferating potential by Ag-NORs staining in human pancreatic carcinoma" Nippon Gekagakkai Zashi. (1993)
T. Aimoto、E. Uchida 等:“通过 Ag-NORs 染色对人胰腺癌的增殖潜力进行研究”Nippon Gekagakkai Zashi。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
相本 隆幸: "ヒト膵癌におけるAgーNORs染色からみた腫瘍細胞増殖能の検討" 日本外科学会雑誌.
Takayuki Aimoto:“通过Ag-NORs染色检查人类胰腺癌中的肿瘤细胞增殖能力”日本外科学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
内田 英二他: "膵癌のmyc,cーerbBー遺伝子産物の発現と悪性度" 胆と膵.
Eiji Uchida 等人:“胰腺癌中 myc、cerbB 基因产物的表达和恶性”胆汁和胰腺。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Experimental pancreatic cancer model using in vivo imaging system and its application
-
批准号:20591556
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2008
-
负责人:UCHIDA Eiji
-
依托单位:
New experimental pancreatic cancer model using real-time in vivo imaging system
-
批准号:18591444
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.8万
-
财政年份:2006
-
负责人:UCHIDA Eiji
-
依托单位:
Evaluation of pharmacodynamics of drugs acting on the central nervous system using computer-assisted eye movement analysis.
-
批准号:09670105
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1997
-
负责人:UCHIDA Eiji
-
依托单位:
海外基金